A clinical study involving 116 lung cancer patients with bone metastasis found significantly higher levels of leptin and its receptor in patients with bone metastases compared to those without, suggesting that the formation of lung adenocarcinoma bone metastatic lesions is closely related to leptin (112). The gene discussed is LEP; the disease is lung carcinoma.